Investigating the safety and efficacy, quality of life, cost-efficiency and immune potential of high precision lung radiotherapy

Project Member(s): Haas, M.

Funding or Partner Organisation: Cancer Australia (Cancer Australia Grant Funding)

Start year: 2015

Summary: This project investigates the safety and efficacy, quality of life, cost-efficiency and immune potential of high precision lung radiotherapy

Publications:

Siva, S, Kron, T, Bressel, M, Haas, M, Mai, T, Vinod, S, Sasso, G, Wong, W, Le, H, Eade, T, Hardcastle, N, Chesson, B, Pham, D, Høyer, M, Montgomery, R & Ball, D 2016, 'A randomised phase II trial of Stereotactic Ablative Fractionated radiotherapy versus Radiosurgery for Oligometastatic Neoplasia to the lung (TROG 13.01 SAFRON II)', BMC Cancer, vol. 16, no. 1.
View/Download from: Publisher's site

FOR Codes: Health Economics, Radiation Therapy, Health Policy Economic Outcomes, Health Policy Evaluation, Health economics , Evaluation of health and support services not elsewhere classified

Acknowledgement of Country

UTS acknowledges the Gadigal people of the Eora Nation, the Boorooberongal people of the Dharug Nation, the Bidiagal people and the Gamaygal people, upon whose ancestral lands our university stands. We would also like to pay respect to the Elders both past and present, acknowledging them as the traditional custodians of knowledge for these lands.